3629 results for «2288»

Filter By

3629 results

Beyond first implant: valve-in-valve, redo and leaflet modification

20 May 2026 – From EuroPCR 2026

This session explores advanced transcatheter aortic valve therapies beyond the first implant, focusing on valve-in-valve, redo procedures, and leaflet modification techniques. Topics include bioprosthetic valve fracture, long-term outcomes from the DURA-ViV registry, simplified workflows for leaflet modification in redo-TAVI, and intravascular ultrasound evaluation of valve expansion...

Beyond first implant:

TAVI complications: the nurses and allied professionals' perspective

20 May 2026 – From EuroPCR 2026

This session highlights the critical role nurses and allied professionals (NAPs) play during TAVI complications. Through detailed clinical cases, it emphasizes their contributions in managing adverse events and explores the significance of structured debriefing to enhance team performance and patient outcomes.

TAVI procedural complications - Part 6: paravalvular leak, basilica and more

20 May 2026 – From EuroPCR 2026

Delve into complex TAVI procedural complications including paravalvular leak and challenges such as BASILICA technique failures, aortic dissection, valve infolding, and valve dislocation. This session presents real-world cases illustrating troubleshooting strategies and innovative interventions like TAVI-in-TAVI procedures to address these critical scenarios.

Intracoronary imaging insights in ACS

20 May 2026 – From EuroPCR 2026

Discover how intracoronary imaging advances understanding and management of acute coronary syndromes (ACS). This session explores high-definition intravascular ultrasound for PCI guidance, novel predictive metrics, and the impact of emerging factors like microplastics on plaque instability, alongside pathophysiological insights into layered plaques and coronary ectasia in...

TAV-in-SAV TAVI procedure - LIVE case

21 May 2026 – From EuroPCR 2026

A 70‑year‑old man with COPD and a history of severe aortic stenosis treated with SAVR (27 mm Perimount Magna) in 2012, followed by endocarditis in 2013, presented with symptomatic degeneration of the surgical valve, predominantly as severe aortic regurgitation. Left ventricular function was preserved (LVEF 50%)...

TAV-in-SAV TAVI procedure - LIVE case

New insights in coronary atherosclerosis using intracoronary imaging

21 May 2026 – From EuroPCR 2026

This session provides new insights into coronary atherosclerosis through intracoronary imaging studies. It investigates the relationship between Lp(a) levels and high-risk plaques, characteristics of vulnerable plaques and thrombus in ACS, non-culprit lesion events, lipid core burden in STEMI, and the prognostic value of AI-derived lipid-to-cap ratios,...

Adopting a step-by-step approach for successful redo TAVI

21 May 2026 – From EuroPCR 2026

This session outlines a systematic step-by-step approach for redo TAVI procedures, including detailed pre-procedural CT analysis. It addresses challenges associated with failing short and tall-frame valves, and discusses coronary protection and leaflet modification techniques critical for successful reinterventions.

Adopting a step-by-step approach for successful redo TAVI

Increasing efficiency in CTO PCI

21 May 2026 – From EuroPCR 2026

Focused on increasing efficiency in CTO PCI, this session covers diverse technical approaches including overcoming unexpected anatomical barriers, multiple wiring techniques, microchannel selection in bifurcation lesions, managing tortuous right coronary artery CTOs, unconventional strategies for uncrossable CTOs, and adapting perspectives in patients with previous CABG.

Innovation in transcatheter mitral valve interventions

21 May 2026 – From EuroPCR 2026

This comprehensive session presents the latest innovations in transcatheter mitral valve interventions, highlighting cutting-edge devices and clinical experiences. Topics include early feasibility studies of novel hemivalve systems, first-in-human experiences with new mitral valve replacement technologies, advances in transcatheter edge-to-edge repair (TEER) with one-year outcome data, and...

When atrial septal closure gets complex

21 May 2026 – From EuroPCR 2026

This session explores the complexities that arise when atrial septal closure procedures become challenging. It covers hybrid retrieval techniques for occluder devices, management of device-related complications mimicking infection, resolution of uncommon complications, and case studies including cryptogenic stroke management in athletes, highlighting procedural intricacies and solutions.

Revascularisation in patients with multivessel disease and severe left ventricular impairment

21 May 2026 – From EuroPCR 2026

This session focuses on revascularisation strategies for patients with multivessel coronary disease complicated by severe left ventricular impairment. It emphasizes patient selection criteria, the crucial role of the heart team in decision-making, and optimization of percutaneous revascularisation outcomes. The content includes comprehensive case presentations and discussions...

Revascularisation in patients with multivessel disease and severe left ventricular impairment

CTO ADVANCED Level I: LIVE Educational Cases from Institut Cardiovasculaire Paris Sud, France & University Hospital Basel, Switzerland

21 May 2026 – From EuroPCR 2026

This advanced level I CTO session features live educational cases from Institut Cardiovasculaire Paris Sud and University Hospital Basel, focusing on structured procedure analysis, imaging-based planning, and integrated CTO techniques. Detailed case presentations and live procedural demonstrations underscore strategies for success in complex CTO interventions.

CTO ADVANCED Level I: LIVE Educational Cases from Institut Cardiovasculaire Paris Sud, France & University Hospital Basel, Switzerland

Advanced heart failure: left ventricular assist device as bridge to optimise guided-directed medical therapy

21 May 2026 – From EuroPCR 2026

This session explores advanced heart failure management with a focus on guided-directed medical therapy and the role of left ventricular assist devices (LVAD) as a bridge to therapy optimization. It discusses clinical, imaging, and biological parameters indicating LVAD use and highlights devices such as the Impella...

Advanced heart failure: left ventricular assist device as bridge to optimise guided-directed medical therapy

Complex PCI - Best cases from PCR Global Interventional Academy - Part 2

21 May 2026 – From EuroPCR 2026

This session showcases best cases from the PCR Global Interventional Academy focusing on complex PCI scenarios. It addresses challenges such as managing ostial left anterior descending artery lesions, strategies for branch protection, implications of coronary involvement during TAVI, and future directions in complex coronary interventions. The...

The impact of calcified and resistant lesions in clinical outcome of PCI

21 May 2026 – From EuroPCR 2026

Delve into the clinical implications of calcified and resistant coronary lesions on percutaneous coronary intervention (PCI) outcomes. This session presents key registry data and study results on intravascular lithotripsy and plaque modification techniques, highlighting their impact on patient prognosis and stent performance.

The impact of calcified and resistant lesions in clinical outcome of PCI

Incorporating CT coronary angiography in the cathlab practice

21 May 2026 – From EuroPCR 2026

Explore the integration of CT coronary angiography into catheterization laboratory practice through real-world studies assessing anatomical yield, diagnostic accuracy, and physiological assessments. The session highlights advancements in myocardial blood flow analysis and plaque characterization to improve ischemia detection and guide invasive angiography.

DCB as a key player in the management of complex coronary lesions

21 May 2026 – From EuroPCR 2026

This session highlights the pivotal role of drug-coated balloons (DCB) in managing complex coronary lesions. Experienced operators share their approaches to applying DCB in challenging clinical and anatomical settings, optimized by intravascular imaging guidance. The discussion includes insights from the LatamBif Registry and other series on...

Novel indications for DCB

21 May 2026 – From EuroPCR 2026

This session reviews emerging clinical applications for drug-coated balloons (DCB) beyond traditional indications. It covers outcomes in venous stenosis, aorto-ostial lesions, and coronary bifurcation disease, comparing DCB strategies with drug-eluting stents and highlighting recent clinical trial findings.

A new horizon in left main and multivessel PCI

21 May 2026 – From EuroPCR 2026

This session explores new horizons in managing left main and multivessel coronary artery disease with PCI. It covers comprehensive evaluation techniques, including physiology and imaging assessments, and advanced PCI strategies for challenging eccentric and heavily calcified lesions. Case presentations from diverse clinical contexts illustrate decision-making and...

TAVI in small annuli - Small anatomies, big challenges

21 May 2026 – From EuroPCR 2026

This session addresses the challenges of transcatheter aortic valve implantation (TAVI) in patients with small aortic annuli. It features registry data comparing valve types, evaluates long-term outcomes, prosthesis-patient mismatch implications, and regional variations in clinical and quality-of-life outcomes.

Didn’t find what you were looking for?